Redefining Your Conference Experience with Excellence!
About The Event
AFSG is delighted to announce the 11th Drug Discovery Strategic Summit (DDSS), in November 10th-11th, 2022, Amsterdam, Netherlands for the two-days of insightful and exciting business development opportunity. This year’s DDSS like our previous summits is packed with great talks from industry top speakers, panel discussion among thought leaders, poster sessions, prescheduled meetings and ground breaking research presentations overcoming the challenges and avenues in drug discovery. Explore our website to learn how all of this and more redefines your networking experience and ensures that you get the maximum out of your time and investment with us.
Main Focus of The Event
Growing The Industry
Industry Thought Leaders Discussing the Challenges of the Market.
Connecting The People
A See-Suite only, designed to help you make connections that matters.
“I would definitely recommend your interesting summit to other people specially people working in small and mid-size companies. I would say that quality of summit was very good because, we had very interesting talks with all the delegates we met. Same goes for prequalified one-to-one meetings protocol.”
Astorgues Xerrs
Preclinical Project Manager of Afr Oncology
- The One to One Meetings will no Longer be for Introductions!






Audience Stats at 11th DDSS




Key Talks You Shouldn’t Miss
Meet the world’s leading drug discovery, development, and data analytics experts
and thought leaders in Amsterdam.

Willem Jespers
Assistant Professor AI & Structure-Based Drug Discovery at University Leiden

Hayley Binch
Head of Medicinal Chemistry at Roche

Alex Macpherson
Senior Principal scientist at UCB

Sebastian Nijman
Founder and Chief Scientific Officer at Scenic Biotech

Mark Krul
Director at Aglaia Oncology Funds

Dr. Jonathan Ward
CEO and Co-Founder

Joachim Pfeifer
Scientific Director at Amgen

Greg Osborne
Director Pharmacology at Sosei Heptares

Matthias Frech
Director Molecular Interactions and Biophysics

David Moreno
Associate Director Early drug discovery

Dilyana Dimova
Senior Data Scientist at Sanofi

Robert Soliva
Head of Drug Discovery at Oryzon Genomics

Jack Gallagher
CEO at CLARITY

Marcel Van Duin
VP Head of External Innovation & Emerging Science At Organon

Roel Arends
Senior Principal Scientist at Byondis BV

Renee Aguiar-Lucander
CEO at Calliditas Therapuetics

Pedro Madureira
Co-founder and CSO at Immunethep

Andreas Bender
Chief Technology and informatics Officer at Pangea Botanical

Michael Thormann
Co-Founder and Managing Director at Origenis

Avinash Patel
Senior Director, Head Exploratory Condensate Science at Dewpoint Therapeutics

Dr. Patrizia A d'Alessio
CEO at Aisa Therapeutics

Dr. Krzysztof B Wicher
VP, Head of Drug Discovery at Macomics
Our venue
We are committed to providing equal access and opportunity for individuals with disabilities. The features also make our hotels more accessible for older individuals with changing abilities to ensure a seamless experience. Our overall goal is to improve usability throughout the hotel for all guests.

Event Headlines
Our aim is to deliver personalized, integrated and measurable conferences that address the unique requirements and goals of our clients. Agile Falcon (AF) Strategic Group conferences get the right requirement to the right audience at the right time.

Keynote Presentations

100+ Attendees

Panel Discussions

One-to-One Meetings




What Our Clients Say About us



We had a fantastic
conference.

